Craft

Rbc Bioscience Corp

Stock Price

NT$19.9

2024-10-29

Market Capitalization

NT$259.5 M

2024-10-29

Revenue

NT$219.7 M

FY, 2025

Rbc Bioscience Corp Summary

Company Summary

Overview
RBC Bioscience is a manufacturer and seller of reagents and devices for life science and molecular diagnosis. It offers real genomics, DNA fragments, plasmids, purification enzymes, nucleic acid extractors, and other products.
Type
Public
Status
Active
Founded
2003
Website
http://rbcbioscience.com
Cybersecurity rating
Sectors

Table of Contents

Rbc Bioscience Corp Financials

Summary Financials

Revenue (FY, 2025)
NT$219.7M
Gross profit (FY, 2025)
NT$109.2M
Net income (FY, 2025)
NT$23.5M
Cash (FY, 2025)
NT$36.4M
EBIT (FY, 2025)
NT$39.2M
Enterprise value
$630.6M

Footer menu